Hillsdale Investment Management Inc.

Position in TVTX — Travere Therapeutics, Inc.

CIK 1368465 Toronto, A6

Position in TVTX

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$9,538,399

+$4,121,672 QoQ

Shares Held

167,900

-7.9% QoQ

Ownership

0.178%

of shares outstanding

% of Portfolio

0.22%

of 13F equity value

Holder Rank

#75

of 315 holders

Holding Since

Jun 2020

8 quarters on record

Voting authority Sole 86% Shared 0% None 14%

Healthcare · as of Jun 30, 2026

Hillsdale Investment Management Inc. holds $115,919,445 across 23 Biotechnology names. TVTX ranks #5 (8.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	55,000	$13,462,350
2	BBIO	BridgeBio Pharma, Inc.	169,112	$12,595,461
3	MRVI	Maravai Lifesciences Holdings, Inc.	1,682,878	$10,501,158
4	ZYME	Zymeworks Inc.	382,922	$10,009,581
5	TVTX	Travere Therapeutics, Inc. This page	167,900	$9,538,399
6	AUPH	Aurinia Pharmaceuticals Inc.	550,900	$9,348,773
7	MIRM	Mirum Pharmaceuticals, Inc.	58,630	$6,863,814
8	ENTA	Enanta Pharmaceuticals Inc	468,000	$6,823,440

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$9,538,399	167,900	-7.9%	Shares	Sole	2026-08-12
2026-03-31	$5,416,727	182,320	+2.9%	Shares	Sole	2026-05-04
2025-12-31	$6,771,576	177,220	-0.7%	Shares	Sole	2026-02-10
2025-09-30	$4,263,760	178,400	+9.2%	Shares	Sole	2025-11-10
2025-06-30	$2,418,320	163,400	+241.1%	Shares	Sole	2025-08-12
2020-12-31	$1,305,514	47,900	—	Shares	Sole	2021-02-09
2020-09-30 RTRX	—	47,900	-0.8%	Shares	Sole	2020-11-13
2020-06-30 RTRX	—	48,300	—	Shares	Sole	2020-08-11
No filing history on record for this holder in this stock.